NEW YORK, Feb. 18, 2020 (GLOBE NEWSWIRE) — Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers,...
New data from the VISIBLE 2 trial presented at the 15th Congress of the European Crohn’s and Colitis Organisation (ECCO) Osaka, JAPAN, February 14, 2020 – Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced results from the phase 3...
Positive Phase 2a stroke clinical data published ReNeuron Group plc (AIM: RENE), a global leader in the development of cell-based therapeutics, is pleased to announce the publication in a peer reviewed journal of positive clinical data from the PISCES II Phase 2a...
There may be hope for an effective plant-based treatment for various head and neck cancers, according to a new study conducted by researchers at UCLA. The organization posted an update to its findings in the last week, which aims to treat the 650,000 cases that are...
(MENAFN – Newsfile Corp) Veritas Pharma Announces Preliminary Clinical Trial Results and the Company’s New Direction Vancouver, British Columbia–(Newsfile Corp. – February 13, 2020) – Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FSE: 2VP)...
Email
Text